NORINCHUKIN BANK, THE – Regeneron Pharmaceuticals, Inc. Transaction History
NORINCHUKIN BANK, THE portfolio value:
$6.92M
portfolio value
NORINCHUKIN BANK, THE quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.76% | 977 shares | 1.56M | $688.87 | 10.05K |
| Q2 2022 | share | Decrease | -17.75% | -1.95K shares | -2.34M | $591.13 | 9.07K |
| Q1 2022 | share | Increase | +10.68% | 1.06K shares | 1.41M | $698.42 | 11.03K |
| Q4 2021 | share | Decrease | -5.06% | -531 shares | -59K | $642.51 | 9.97K |
| Q3 2021 | share | Increase | +6.23% | 616 shares | 834K | $605.18 | 10.50K |
| Q2 2021 | share | Increase | +1.33% | 130 shares | 906K | $558.54 | 9.88K |
| Q1 2021 | share | Increase | +5.00% | 465 shares | 127K | $473.14 | 9.75K |
| Q4 2020 | share | Decrease | -0.12% | -11 shares | -718K | $483.11 | 9.29K |
| Q3 2020 | share | Increase | +7.01% | 609 shares | -214K | $559.78 | 9.30K |
| Q2 2020 | share | Increase | +23.30% | 1.64K shares | 1.97M | $623.65 | 8.69K |
| Q1 2020 | share | Decrease | -35.34% | -3.85K shares | -652K | $488.29 | 7.05K |
| Q4 2019 | share | Decrease | -7.43% | -875 shares | 827K | $375.48 | 10.90K |
| Q3 2019 | share | Increase | +3.68% | 418 shares | -289K | $277.4 | 11.77K |
| Q2 2019 | share | Decrease | -25.17% | -3.82K shares | -2.67M | $313 | 11.36K |
| Q1 2019 | share | Increase | +4.84% | 701 shares | 826K | $410.62 | 15.18K |
| Q4 2018 | share | Increase | +45.29% | 4.51K shares | 1.38M | $373.5 | 14.48K |
| Q3 2018 | share | Increase | +13.72% | 1.20K shares | 1.00M | $404.04 | 9.96K |
| Q2 2018 | share | Increase | +23.86% | 1.68K shares | 586K | $344.99 | 8.76K |
| Q1 2018 | share | Increase | +14.87% | 916 shares | 121K | $344.36 | 7.07K |
| Q4 2017 | share | Increase | +7.71% | 441 shares | -241K | $375.96 | 6.16K |
| Q3 2017 | share | Increase | +8.15% | 431 shares | -40K | $447.12 | 5.71K |
| Q2 2017 | share | Increase | +7.00% | 346 shares | 682K | $491.14 | 5.28K |
| Q1 2017 | share | Increase | +7.74% | 355 shares | 231K | $387.51 | 4.94K |
| Q4 2016 | share | Increase | +13.48% | 545 shares | 59K | $367.09 | 4.58K |
| Q3 2016 | share | Decrease | -1.20% | -49 shares | 196K | $402.02 | 4.04K |
| Q2 2016 | share | Increase | +2.10% | 84 shares | -15K | $349.23 | 4.09K |
| Q1 2016 | share | Increase | +10.48% | 380 shares | -525K | $360.44 | 4.00K |